SCHEMBL12439282

SCHEMBL12439282

O=CCC(CCO)(CCO)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7944644 0.75 ALDH1A1 (0.35)
SCHEMBL945265 0.69 TSHR (0.36)
SCHEMBL28132806 0.69
SCHEMBL7119977 0.67 ALDH1A1 (0.33)
SCHEMBL20873220 0.66 TSHR (0.37)
SCHEMBL1915862 0.66 ARG2 (0.47)
SCHEMBL409753 0.63 TSHR (0.41)
SCHEMBL12191378 0.63 TSHR (0.41)
SCHEMBL176426 0.63 TSHR (0.41)
SCHEMBL13642563 0.63 CAMK2A (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160324974-A1 METHOD FOR PREPARING A POLYMERIC REAGENT NEKTAR THERAPEUTICS 2016-11-10 US disclosed
US-9399070-B2 Compositions comprising a polymeric reagent and a pharmacologically active agent NEKTAR THERAPEUTICS (US) 2016-07-26 US disclosed
US-20150328331-A1 Compositions Comprising a Polymeric Reagent and a Pharmacologically Active Agent NEKTAR THERAPEUTICS (US) 2015-11-19 US disclosed
US-9044516-B2 Pharmaceutical compositions of conjugates formed from polymer derivatives having particular atom arrangements NEKTAR THERAPEUTICS (US) 2015-06-02 US disclosed
US-20140227218-A1 Pharmaceutical Compositions of Conjugates Formed From Polymer Derivatives Having Particular Atom Arrangements NEKTAR THERAPEUTICS (US) 2014-08-14 US disclosed
US-8633277-B2 Methods for forming polymer-drug conjugates NEKTAR THERAPEUTICS (US) 2014-01-21 US disclosed
US-20110178242-A1 Methods for Forming Polymer-Drug Conjugates NEKTAR THERAPEUTICS (US) 2011-07-21 US disclosed
US-7947261-B2 Moiety is positioned between a water-soluble polymer and a reactive group; water soluble polymer such as polyethylene glycol containing a urethane linkage moiety for example, and a reactive group for conjugating with biodrugs NEKTAR THERAPEUTICS (US) 2011-05-24 US disclosed
US-7887789-B2 Polymer derivatives having particular atom arrangements NEKTAR THERAPEUTICS (US) 2011-02-15 US disclosed